ERG antibody (full length)

Catalog No. ABIN7878179

This Mouse Monoclonal antibody specifically detects ERG in IHC (p). It exhibits reactivity toward Human.

Quick Overview for ERG antibody (full length) (ABIN7878179)

Target: ERG (ERG, ETS transcription factor (ERG))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This ERG antibody is un-conjugated

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Grade: Carrier-free

Clone: ERG-2107

Product Details anti-ERG Antibody

Binding Specificity: full length

Purpose: ERG Antibody / Transcriptional regulator ERG (azide and preservative free)

Purification: Protein A/G affinity

Immunogen: Recombinant human full-length ERG protein was used as the immunogen for the ERG antibody.

Isotype: IgG2b, kappa

Application Details

Application Notes: Optimal dilution of the ERG antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: -20 °C

Storage Comment: Aliquot the ERG antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for ERG

Target: ERG (ERG, ETS transcription factor (ERG))

Alternative Name: ERG

Background: The transcription factor erythroblastosis virus E26 transforming sequence related gene (ERG) functions as a regulator of key cellular functions to promote endothelial homeostasis. Expression of ERG has been observed in both benign and malignant vascular endothelial tumors, such as hemangiomas and Kaposi sarcomas, respectively. Carcinomas of the breast, colon, and urothelium have demonstrated absence of ERG expression, whereas presence of the protein has been confirmed in a subset of prostate carcinoma cases. Anti-ERG can be a useful tool for identifying vascular endothelial neoplasms and distinguishing prostate carcinoma from epithelial tumors of non-prostatic origin.

UniProt: P11308